THYROID-HORMONE RECEPTORS AND 3,5,3'-TRIIODOTHYRONINE BIOLOGICAL EFFECTS IN FRTL5 THYROID FOLLICULAR CELLS

被引:18
|
作者
AKIGUCHI, I
STRAUSS, K
BORGES, M
SILVA, JE
MOSES, AC
机构
[1] BETH ISRAEL HOSP,THORNDIKE LABS,CHARLES A DANA RES INST,DEPT MED,THYROID UNIT,BOSTON,MA 02215
[2] BETH ISRAEL HOSP,THORNDIKE LABS,CHARLES A DANA RES INST,DEPT MED,BOSTON,MA 02215
关键词
D O I
10.1210/en.131.3.1279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Specific thyroid hormone (T3) receptors are present in thyroid follicular cells, including the rat FRTL5 clonal line, but little is known about the effects of T3 on the growth and differentiated function of the thyroid. Unlike primary cultures of animal or human thyroid cells, FRTL5 do not secrete appreciable amounts of thyroid hormones. We now have studied the effects of T3 by itself and in combination with TSH and insulin-like growth factor-I (IGF-I) on [H-3]thymidine incorporation into DNA, iodide uptake, and cAMP production in FRTL5. We also have investigated the expression of different c-erbA mRNAs in these cells. Specific binding of T3 to FRTL5 cell nuclei in intact cells occurred with a binding capacity of 0.1-0.15 ng T3/mg DNA and an apparent K(d) of 0.4 nm. Using an RNase protection assay on total cellular FRTL5 RNA and specific cRNA probes, we demonstrated the presence of c-erbA-alpha and -beta mRNAs, both encoding T3 receptors. Biological effects were assessed in serum-free medium or buffer containing 0.1% BSA after maintaining quiescent culture of cells for at least 5 days in hormone-free medium containing 5% calf serum. T3 alone stimulated a dose-dependent increase in [H-3]thymidine incorporation that reached a plateau at 188% of the control value at 10 nM T3. At 10(-11) M TSH, T3 potentiated TSH-stimulated [H-3]thymidine incorporation (2.2-fold), but at TSH concentrations greater than 5 x 10(-11) m, T3 had no effect or reduced the response to TSH. T3 potentiated the [H-3]thymidine response to 2 and 10 ng/ml IGF-I by 1.5- to 1.7-fold. T3 alone had no effect on iodide uptake, but attenuated iodide uptake stimulated by TSH. T3 was more potent in inhibiting TSH-stimulated iodide uptake than in enhancing TSH-stimulated DNA synthesis. T3 did not affect either basal or TSH-stimulated cAMP accumulation. Thus, in FRTL5 thyroid follicular cells 1) T3 receptors are expressed, as measured by direct binding assays and by the expression of c-erbA mRNAs; and 2) T3 acts as a growth factor and weak antidifferentiation factor. We suggest that T3 may modulate the actions of TSH and growth factors in thyroid epithelium.
引用
下载
收藏
页码:1279 / 1287
页数:9
相关论文
共 50 条
  • [1] 3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells
    Agretti, Patrizia
    De Marco, Giuseppina
    Russo, Laura
    Saba, Alessandro
    Raffaelli, Andrea
    Marchini, Maja
    Chiellini, Grazia
    Grasso, Lucia
    Pinchera, Aldo
    Vitti, Paolo
    Scanlan, Thomas S.
    Zucchi, Riccardo
    Tonacchera, Massimo
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2011, 47 (01) : 23 - 32
  • [3] THYROXINE, 3,5,3'-TRIIODOTHYRONINE, AND 3,3',5-TRIIODOTHYRONINE CONCENTRATIONS IN SEVERAL TISSUES OF THE RAT - EFFECTS OF AMIODARONE AND DESETHYLAMIODARONE ON THYROID-HORMONE METABOLISM
    SCHRODERVANDERELST, JP
    VANDERHEIDE, D
    ENDOCRINOLOGY, 1990, 127 (04) : 1656 - 1664
  • [4] A NEW METHOD FOR QUANTITATING INTRACELLULAR-TRANSPORT - APPLICATION TO THE THYROID-HORMONE 3,5,3'-TRIIODOTHYRONINE
    LUXON, BA
    WEISIGER, RA
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05): : G733 - G741
  • [5] 3,5,3'-TRIIODOTHYROACETIC ACID THERAPY FOR THYROID-HORMONE RESISTANCE
    KUNITAKE, JM
    HARTMAN, N
    HENSON, LC
    LIEBERMAN, J
    WILLIAMS, DE
    WONG, M
    HERSHMAN, JM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (02): : 461 - 466
  • [6] A POINT MUTATION IN THE 3,5,3'-TRIIODOTHYRONINE-BINDING DOMAIN OF THYROID-HORMONE RECEPTOR-BETA ASSOCIATED WITH A FAMILY WITH GENERALIZED RESISTANCE TO THYROID-HORMONE
    SHUTO, Y
    WAKABAYASHI, I
    AMURO, N
    MINAMI, S
    OKAZAKI, T
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (01): : 213 - 217
  • [7] Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone
    Ueda, S
    Takamatsu, J
    Fukata, S
    Tanaka, K
    Shimizu, N
    Sakata, S
    Yamaji, T
    Kuma, K
    Ohsawa, N
    THYROID, 1996, 6 (06) : 563 - 570
  • [8] 3,5,3'-TRIIODOTHYROACETIC ACID (TRIAC) THERAPY FOR THYROID-HORMONE RESISTANCE
    KUNITAKE, JM
    HARTMAN, N
    ERIKSEN, EM
    LEBRON, BA
    HERSHMAN, JM
    CLINICAL RESEARCH, 1988, 36 (01): : A124 - A124
  • [9] ROLES OF 3,5,3'-TRIIODOTHYRONINE AND DEOXYRIBONUCLEIC-ACID BINDING ON THYROID-HORMONE RECEPTOR COMPLEX-FORMATION
    YEN, PM
    BRUBAKER, JH
    APRILETTI, JW
    BAXTER, JD
    CHIN, WW
    ENDOCRINOLOGY, 1994, 134 (03) : 1075 - 1081
  • [10] PLASMA-CONCENTRATIONS OF THYROID-HORMONE IN STEERS TREATED WITH SYNONEX-S(R) AND 3,5,3'-TRIIODOTHYRONINE
    KAHL, S
    RUMSEY, TS
    ELSASSER, TH
    KOZAK, AS
    JOURNAL OF ANIMAL SCIENCE, 1992, 70 (12) : 3844 - 3850